Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05227144 |
| Title | Study of ORIC-533 in Relapsed or Refractory Multiple Myeloma |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | ORIC Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| James R. Berenson, MD, Inc. | West Hollywood | California | 90069 | United States | Details | |
| Northside Hospital Cancer Institute | Atlanta | Georgia | 30342 | United States | Details | |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
| Mayo Clinical Rochester | Rochester | Minnesota | 55905 | United States | Details | |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | United States | Details | |
| The Charlotte-Mecklenburg Hospital Authority d/b/a Atrium Health | Charlotte | North Carolina | 28203 | United States | Details | |
| Swedish Health Services | Seattle | Washington | 98107 | United States | Details | |
| Princess Margaret Cancer Research Center/University Health Network | Toronto | Ontario | Canada | Details |